Prophylaxis Against Anthrax

Špliňo, Miroslav; Patočka, Jiří

doi:10.14712/18059694.2019.60

Acta Medica > Archive > 2002, Vol. 45 > Issue 3 > Prophylaxis Against Anthrax

Acta Med. 2002, 45: 85-88

https://doi.org/10.14712/18059694.2019.60

Prophylaxis Against Anthrax

Miroslav Špliňo^a, Jiří Patočka^b

^aPurkyně Military Medical Academy in Hradec Králové, Department of Epidemiology, Hradec Králové, Czech Republic
^bPurkyně Military Medical Academy in Hradec Králové, Department of Toxicology, Hradec Králové, Czech Republic

Received April 1, 2002
Accepted July 1, 2002

The paper presents fundamental knowledge concerning Bacillus anthracis and its potential terrorist misuse. The basic clinical forms are resumed with emphasis on inhalation infection from inspiration of B. anthracis spores. The AVA vaccine licensed in the United States, primary vaccination, protective efficacy of the vaccine, and adverse events are characterised. Stress is laid on pre-exposure and post-exposure prophylaxis of anthrax.